Here are the company’s fourth quarter results:
1. K2M will likely see revenue between $67.3 million and $67.9 million, reflecting a 9 percent to 10 percent year-over-year increase.
2. Domestically, the revenue will land somewhere between $51.7 million and $52 million, a 9 percent year-over-year boost.
3. Specifically, the company’s U.S. complex spine line grew 8 percent year-over-year and the minimally invasive surgery line grew 15 percent year-over year. The U.S. degenerative segment saw an 8 percent boost year-over-year.
4. K2M’s international revenue hit between $15.6 million and $15.9 million, an 11 percent to 13 percent increase year-over-year.
Here are K2M’s FY 2017 results:
5. The company reported revenue between $257.5 million $258.1 million, a 9 percent year-over-year increase.
6. K2M anticipates its full-year 2017 net loss and adjusted EBITDA to reflect its reported guidance.
More articles on devices:
Medtronic, DePuy Synthes & more: 8 device company mergers, acquisitions & agreements
DJO Global reports patient information breach at Las Vegas hospital: 5 things to know
NuVasive’s US procedure volumes stay slow in 2017, international revenue up: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
